News & Insights

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]

We are pleased to share our introduction to Pharma Licensing. This guide provides an overview of both in and out-licensing as well as insights on what to anticipate during the process. We hope that you find this guide useful and look forward to discussing the underlying themes with you. Do get in touch! Click to […]

Welcome to our MedTech Services Report. This sets out our views on the tailwinds driving growth and increased outsourcing, an overview of the MedTech CDMO and CRO market as well as the key drivers of consolidation in the sector. We hope that you enjoy this report and look forward to discussing the data and underlying […]

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector.  As well as our usual update on M&A activity, this report takes a deep dive into one of the biggest challenges businesses are currently facing – the War for Talent. A phrase first coined by McKinsey in the late ’90s but one that […]

We are pleased to share with you the H1 2022 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. H1 2022 has been an exciting and active period for M&A in the marketing services vertical with 425 deals recorded globally. This represents a 15% and […]

H1 2022 deal volumes have increased significantly across the board, up 37% over H1 2021. Strategic M&A continues to drive this quarter’s deal activity, namely acquiring footholds in near/offshore hotspots, vendor-specific tech stacks (particularly AWS, Salesforce and SAP) and or next-gen capabilities, such as conversational AI and data analytics. Public tech companies broadly tracked the […]

Cybersecurity multiples remain at a higher level than other technology verticals and revenue multiples are trading above pre-COVID 19 levels, whilst M&A volumes and values continue to outpace other sectors – all in spite of widespread depressed public market valuations. With the sector expected to strengthen against the increasing sophistication of hackers, established players continue […]

The private M&A markets recorded just north of 500 deals for the quarter, a number significantly greater than that recorded in Q2 of 2021 (399), and well above pre-pandemic levels. This quarter further witnessed one of the biggest acquisitions in tech history – Broadcom’s $69Bn acquisition of VMware, as the chipmaker seeks to diversify and […]

Private deal activity and valuations within the global technology market remain high in spite of macroeconomic uncertainty. M&A continues to be driven by further adoption of cloud and next-gen technologies, increased focus on strategic tuck-ins, and launching in new markets. As geopolitical uncertainty continues to impact public markets, the outlook for the second half of […]